whatshot

BCAX   $20.85  -2.89% Market Closed After Close 20.84 -0.05%

Bicara Therapeutics Inc.
show_chart Advanced Chart of BCAX

Current temperature: 1.47
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 12
Target Price Mean 30.50
Mean unverified/preliminary 30.50 / 30.50
Target Price Low / High 16.00 / 48.00
Median / STD DEV 30.50 / 10.01
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total ActivelyBuy ActivelyBuy ActivelyBuy
rsi Sell ActivelyBuy None
macd None None None
stoch None None None
ma20 Sell ActivelyBuy None
ma50 None None None
ma100 ActivelyBuy Buy ActivelyBuy
Candlestick PatternMarch 24, 2026 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US0554771032
ceo Ms. Claire Mazumdar Clemon M.B.A., Ph.D.
Website https://www.bicara.com
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-b) for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.